XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.85%25.1B | 5.48%6.43B | 5.52%6.26B | 5.99%6.44B | 6.45%5.98B | 14.15%23.71B | 2.90%6.1B | 11.58%5.93B | 13.81%6.08B | 33.72%5.62B |
Operating revenue | 5.21%6.72B | 3.12%1.75B | 6.67%1.66B | 5.98%1.74B | 5.18%1.54B | 17.32%6.39B | 11.26%1.7B | 11.11%1.56B | 15.66%1.64B | 39.41%1.47B |
Cost of revenue | 7.59%20B | 6.05%5.29B | 9.93%4.98B | 6.19%4.94B | 8.38%4.79B | 14.64%18.59B | 7.41%4.99B | 10.86%4.53B | 13.27%4.65B | 30.84%4.42B |
Gross profit | -0.45%5.1B | 2.89%1.14B | -8.80%1.27B | 5.34%1.5B | -0.67%1.19B | 12.42%5.12B | -13.45%1.11B | 13.95%1.4B | 15.61%1.42B | 45.57%1.2B |
Operating expense | 4.75%1.26B | -12.07%335M | 12.63%321M | 2.43%295M | 24.39%306M | 10.70%1.2B | 35.11%381M | 7.14%285M | 2.86%288M | -3.91%246M |
Selling and administrative expenses | 6.23%1.07B | -12.42%289M | 15.48%276M | 3.33%248M | 29.21%261M | 13.47%1.01B | 39.83%330M | 10.65%239M | 3.90%240M | -2.88%202M |
-General and administrative expense | 6.23%1.07B | -12.42%289M | 15.48%276M | 3.33%248M | 29.21%261M | 13.47%1.01B | 39.83%330M | 10.65%239M | 3.90%240M | -2.88%202M |
Depreciation amortization depletion | -3.17%183M | -9.80%46M | -2.17%45M | -2.08%47M | 2.27%45M | -2.07%189M | 10.87%51M | -8.00%46M | -2.04%48M | -8.33%44M |
-Depreciation and amortization | -3.17%183M | -9.80%46M | -2.17%45M | -2.08%47M | 2.27%45M | -2.07%189M | 10.87%51M | -8.00%46M | -2.04%48M | -8.33%44M |
Operating profit | -2.04%3.84B | 10.74%804M | -14.30%953M | 6.08%1.2B | -7.14%884M | 12.95%3.92B | -27.18%726M | 15.83%1.11B | 19.37%1.13B | 67.90%952M |
Net non-operating interest income expense | -22.43%-655M | -18.06%-170M | -20.86%-168M | -16.31%-164M | -37.84%-153M | -41.91%-535M | -34.58%-144M | -49.46%-139M | -58.43%-141M | -26.14%-111M |
Non-operating interest income | 33.33%40M | 11.11%10M | 57.14%11M | --9M | -33.33%10M | 15.38%30M | 12.50%9M | 0.00%7M | ---- | 200.00%15M |
Non-operating interest expense | 23.01%695M | 17.65%180M | 22.60%179M | 22.70%173M | 29.37%163M | 40.20%565M | 33.04%153M | 46.00%146M | 48.42%141M | 35.48%126M |
Other net income (expense) | -245.45%-38M | -3,500.00%-36M | -93.75%1M | 103.45%1M | -233.33%-4M | -164.71%-11M | -200.00%-1M | 700.00%16M | -270.59%-29M | 200.00%3M |
Earnings from equity interest | -11.11%8M | --0 | 200.00%3M | -28.57%5M | --0 | -50.00%9M | --0 | 0.00%1M | -53.33%7M | -50.00%1M |
Special income (charges) | -28.33%-77M | -550.00%-52M | 30.77%-9M | 78.95%-8M | -700.00%-8M | -400.00%-60M | -700.00%-8M | -550.00%-13M | ---38M | 88.89%-1M |
-Less:Restructuring and merger&acquisition | 28.33%77M | 550.00%52M | -30.77%9M | -78.95%8M | 700.00%8M | 400.00%60M | 700.00%8M | 550.00%13M | --38M | -88.89%1M |
Other non- operating income (expenses) | -22.50%31M | 128.57%16M | -75.00%7M | 100.00%4M | 33.33%4M | 263.64%40M | 250.00%7M | 833.33%28M | 0.00%2M | -25.00%3M |
Income before tax | -6.72%3.15B | 2.93%598M | -20.53%786M | 7.88%1.04B | -13.86%727M | 8.48%3.38B | -34.79%581M | 13.81%989M | 9.79%964M | 77.31%844M |
Income tax | 163.05%776M | 153.56%143M | -14.77%202M | 12.61%268M | 87.36%163M | -60.98%295M | -222.48%-267M | -0.84%237M | 19.00%238M | -12.12%87M |
Net income | -22.96%2.38B | -46.34%455M | -22.34%584M | 6.34%772M | -25.50%564M | 30.75%3.08B | 26.00%848M | 19.37%752M | 7.08%726M | 100.80%757M |
Net income continuous Operations | -22.96%2.38B | -46.34%455M | -22.34%584M | 6.34%772M | -25.50%564M | 30.75%3.08B | 26.00%848M | 19.37%752M | 7.08%726M | 100.80%757M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -22.96%2.38B | -46.34%455M | -22.34%584M | 6.34%772M | -25.50%564M | 30.75%3.08B | 26.00%848M | 19.37%752M | 7.08%726M | 100.80%757M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -22.96%2.38B | -46.34%455M | -22.34%584M | 6.34%772M | -25.50%564M | 30.75%3.08B | 26.00%848M | 19.37%752M | 7.08%726M | 100.80%757M |
Basic earnings per share | -18.28%8.36 | -43.40%1.63 | -17.46%2.08 | 12.97%2.7 | -20.49%1.94 | 40.72%10.23 | 35.21%2.88 | 29.90%2.52 | 16.02%2.39 | 112.17%2.44 |
Diluted earnings per share | -18.17%8.33 | -43.21%1.63 | -17.53%2.07 | 13.03%2.69 | -20.58%1.93 | 40.61%10.18 | 35.38%2.87 | 29.38%2.51 | 15.53%2.38 | 113.16%2.43 |
Dividend per share | 22.96%2.41 | 21.15%0.63 | 21.15%0.63 | 21.15%0.63 | 30.00%0.52 | 96.00%1.96 | 30.00%0.52 | 73.33%0.52 | 73.33%0.52 | 0.4 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |